Nachfolgend sind alle Publikationen des Departments aufgelistet.

In der Forschungsdatenbank der Universität für Weiterbildung Krems gibt es die Möglichkeit, mittels Suchfunktion nach AutorInnen oder bestimmten Publikationen zu suchen.

Sharifan, A. (2025). Navigating the grey area: “Trend” statements to report statistical findings in the critical care literature. Journal of Critical Care, 89: 155162

Nevill, C.R.; Sharifan, A.; O'Mahony, A.; Tahir, H.; Robinson, W.; Modha, U.; Kahale, L.A.; Khamis, A.M.; Akl, E.A.; Smith, E.A.; Sutton, A.J.; Freeman, S.C.; Cooper, N.J. (2025). Capturing the influx of living systematic reviews: a systematic methodological survey. Journal of Clinical Epidemiology, 186: 111904

Nevill, C.R.; Sharifan, A.; O'Mahony, A.; Tahir, H.; Robinson, W.; Modha, U.; Kahale, L.A.; Khamis, A.M.; Akl, E.A.; Smith, E.A.; Sutton, A.J.; Freeman, S.C.; Cooper, N.J. (2025). Capturing the influx of living systematic reviews: a systematic methodological survey. Journal of Clinical Epidemiology, 186: 111904

Sharifan, A. (2025). Navigating the grey area: “Trend” statements to report statistical findings in the critical care literature. Journal of Critical Care, 89: 155162

Rafferty, Q.; Stafford, L.K.; Vos, T.; Thomé, F.S.; Aalruz, H.; Abate, Y.H.; et al. Sharifan, A.; (2025). Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Global Health, Vol. 13 Issue 8: e1378-e1395

Ledinger, D.; Nussbaumer-Streit, B.; Piso, B.; Dobrescu, A.; Gadinger, A.; Klerings, I.; Hohenfellner, K.; Sommer, I. (2025). Diagnosis and management of cystinosis: systematic review for a clinical practice guideline. Orphanet Journal of Rare Diseases, 20: 463

Ledinger, D.; Nussbaumer-Streit, B.; Piso, B.; Dobrescu, A.; Gadinger, A.; Klerings, I.; Hohenfellner, K.; Sommer, I. (2025). Diagnosis and management of cystinosis: systematic review for a clinical practice guideline. Orphanet Journal of Rare Diseases, 20: 463

Rafferty, Q.; Stafford, L.K.; Vos, T.; Thomé, F.S.; Aalruz, H.; Abate, Y.H.; et al. Sharifan, A.; (2025). Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Global Health, Vol. 13 Issue 8: e1378-e1395

Haeuser, E.; Byrne, S.; Nguyen, J.; Raggi, C.; McLaughlin, S.A.; Bisignano, C.; et al. Sharifan, A: (2025). Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet, Volume 406, Issue 10500: 235-260

Sharifan, A. (2025). From “No Difference” to “Trending”: misinterpretation of statistical analysis in animal studies. Naunyn-Schmiedeberg's Archives of Pharmacology, https://doi.org/10.1007/s00210-025-04440-0: https://doi.org/10.1007/s00210-025-04440-0

Haeuser, E.; Byrne, S.; Nguyen, J.; Raggi, C.; McLaughlin, S.A.; Bisignano, C.; et al. Sharifan, A: (2025). Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet, Volume 406, Issue 10500: 235-260

Sharifan, A. (2025). From “No Difference” to “Trending”: misinterpretation of statistical analysis in animal studies. Naunyn-Schmiedeberg's Archives of Pharmacology, https://doi.org/10.1007/s00210-025-04440-0: https://doi.org/10.1007/s00210-025-04440-0

Sharifan, A.; Fonarow, G. (2025). Towards accurate interpretation of hypothesis testing in cardiology randomised controlled clinical trials. Heart, Online first: 10.1136/heartjnl-2025-326515

Seidl, K.; Wahl, A.; Rojatz, D.; Affengruber, L.; Sommer, I.; Klerings, I.; Gugglberger, L.; Nash, R.; Mahr-Slotawa, J.; Griebler, U. (2025). How Best to Perform Co-Research With Children and Adolescents: A Rapid Qualitative Evidence Synthesis. International Journal of Qualitative Methods, 24: 1-36

Sharifan, A. (2025). Bridging knowledge gaps in phytotherapy for a neglected zoonotic disease: Rift valley fever. Biomedicine & Pharmacotherapy, 187: https://doi.org/10.1016/j.biopha.2025.118092

Sharifan, A.; Fonarow, G. (2025). Towards accurate interpretation of hypothesis testing in cardiology randomised controlled clinical trials. Heart, Online first: 10.1136/heartjnl-2025-326515

Sofi-Mahmudi, A.; Stojanova, J.; Vounzoulaki, E.; Tomlinson, E.; Pizarro, A.B.; Khademioore, S.; Ngeh, E.; Sharifan, A.; Mrema, L.E.; Britten-Jones, A.C.; Castiello de Obeso, S.; Welch, V.A.; Mbuagbaw, L.; Tugwell, P. (2025). Cochrane reviews’ authorship has become more gender-diverse but remains geographically concentrated: a meta-research study. Journal of Clinical Epidemiology, 181: https://doi.org/10.1016/j.jclinepi.2025.111719

GBD 2021 Global Subarachnoid Hemorrhage Risk Factors Collaborators (2025). Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage. The Global Burden of Disease Study 2021. JAMA Neurology, 10.1001/jamaneurol.2025.1522: E1-E23

Oh, J.; Kim, S.; Kim, M. S.; Abate, Y. H.; Abd ElHafeez, S.; Abdelkader, A.; et al. (2025). Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. The Lancet Respiratory Medicine, 13, 5: 425-446

Meixner, J.; Nußbaumer-Streit, B.; Sommer, I. (2025). Update der WHO-Leitlinie zur Diagnostik, medikamentösen Prophylaxe und Behandlung von Influenza. Das Gesundheitswesen, Online ahead of print.: DOI: 10.1055/a-2571-3357

Mehr laden
von
Zum Anfang der Seite